Sponsors
Blog
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Business Strategies & IT
The technical side of business
GlaxoSmithKline’s Bill Louv tells Natalie Brandweiner of technology’s role in ensuring successful business solutions, and the responsibility of ensuring the company’s success.
Tackling the issue of failing research productivity
Increasing productivity is a fundamental challenge of life sciences research. Research-driven companies have tackled this productivity issue through large, top down initiatives. McKinsey has taken a different approach.
Nycomed sustains commitment to Russia-CIS and invests in new pharmaceutical production plant
The new facility will produce medicines for the local Russia-CIS market, which contributes 10% to Nycomed's turnover and plays an important role in the company's growth strategy.
Slim down with lean quality
During these turbulent economic times, everybody is talking about slimming down and becoming lean. The top 16 pharmaceutical manufacturers spent over $90 billion to manufacture drugs but half is considered wasted money and an estimated 95% of activities in any pharmaceutical plant fail to add value to the product.
Back on track
Martin Mackay fills NGP in on his plan to improve the ROI of Pfizer's R&D.
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.